Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Future Approaches to Precision Oncology-Based Clinical TrialsArjun Mittra, Jeffrey A MoscowCell Biology International|May 25, 2010
Addressing the design of in vitro models for the investigation of microcystins: the essential role of transporter-mediated uptakeNoel R Monks, Jeffrey A MoscowJournal of the National Cancer Institute|December 19, 2022
Dose optimization during drug development: whether and when to optimizeEdward L Korn, Jeffrey A Moscow, Boris FreidlinNature Reviews. Clinical Oncology|December 20, 2017
The evidence framework for precision cancer medicineJeffrey A Moscow, Tito Fojo, Richard L SchilskyFrontiers in Oncology|December 6, 2021
Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-OncologyAshish Manne, Edward Woods, Allan Tsung, et al.Cancers|May 14, 2025
The Combined Use of Lenvatinib and Locoregional Therapies for the Management of Hepatocellular CarcinomaRonit Juthani, Pannaga Malalur, Ashish Manne, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapyYu Fujiwara, Arjun Mittra, Abdul Rafeh Naqash, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Basolateral active uptake of nitrofurantoin in the CIT3 cell culture model of lactationPhillip M Gerk, Jeffrey A Moscow, Patrick J McNamaraPediatric Hematology and Oncology|June 24, 2008
Spontaneous resolution of a single lesion of myeloid leukemia cutis in an infant: case report and discussionJohn A D'Orazio, Joseph F Pulliam, Jeffrey A MoscowToxicon : Official Journal of the International Society on Toxinology|December 1, 2009
Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibitionAbigail Daily, Noel R Monks, Markos Leggas, et al.Pageof 10